In addition, baicalin can inhibit the activation of the glycogen synthase kinase-3 beta (GSK3β)/NF-κB/NLRP3 pathway, promoting neuronal maturation and protecting against neuronal damage, thereby alleviating CUMS-induced depression-like behavior (130). Here, GSK3B is linked to depressive symptom measurement.